Hamilton Thomas Edward bought LRMR
May 19, 2026 · Form 4 insider transaction
Hamilton Thomas Edward bought 55,150 shares of Larimar Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
55,150
Price
$0.00
Total value
N/A
InsiderHamilton Thomas Edward
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 19, 2026
Filing dateMay 20, 2026
Shares owned after55,150
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.